More News
18 October 2024
Chengdu Baiyu enters into a license agreement for the development and commercialization of its Anti-tumor small molecule inhibitor14 October 2024
Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline10 October 2024
Novo Holdings Launches Portfolio Company Booster Therapeutics to Advance New Class of Small Molecule Proteasome Activator Therapeutics9 October 2024
Boehringer Ingelheim and Circle Pharma announce new research collaboration to develop a novel precision cancer treatment8 October 2024
AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy2 October 2024
CAMP4 Enters Strategic Research Collaboration to Advance Novel Regulatory RNA-Targeting Medicines for Rare Genetic Conditions30 September 2024
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company25 September 2024
Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI23 September 2024
Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform18 September 2024
NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases18 September 2024
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%18 September 2024
Nura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million17 September 2024
Mindpeak Announces Collaboration With Roche to Enhance Cancer Diagnostics Through AI16 September 2024
Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected16 September 2024
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates16 September 2024
Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 in Metastatic Melanoma at 2024 ESMO Annual Meeting10 September 2024
Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies6 September 2024
Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AINews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports